Samsung Bioepis demonstrates efficacy of first biosimilar for eye disease treatment
GC Pharma pledges unlimited free supply of immunoglobulin drug for plasma treatment
Bill Gates Foundation to finance research projects by S. Korean companies
Nafamostat selected by researchers as most potent COVID-19 drug candidate
British biotech firm Iksuda to receive drug candidate materials from S. Korean partner LegoChem
French partner Sanofi decides to returns rights related to Hanmis diabetes drug candidate
Antimalarial medicine Pyramax approved for coronavirus clinical trials
[Coronavirus] GC Pharma selected for state project to develop plasma treatment
[Coronavirus] Seoul mayor proposes special hospital for infectious disease in downtown area
Researchers use octopus neuromodulator to treat cognitive disorders or depression
[Coronaviru] Hydroxychloroquine tested at care hospital to find efficacy as COVID-19 drug
[Coronavirus] Research team warns of COVID-19-related inflammation of heart muscle
Samsung Bioepis cancer-treating biosimilar Ontruzant is available in U.S.
[Coronavirus] Celltrion selects 14 antibodies with strong capability to neutralize virus
Researchers develop wearable airbag vest to prevent accidental infant suffocation
[Coronavirus] Mouse models for research in August to verify effectiveness of COVID-19 vaccine, medicine
[Coronavirus] Samsung BioLogics wins deal from Vir Biotechnology to produce candidate material for COVID-19 treatment
[Coronavirus] Researchers open new direction to investigate virus mechanism
[Coronavirus] Health officials propose collection of convalescent plasma at hospitals
[Coronavirus] Researchers localize life-saving medical equipment